Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
81,092,174
-
Shares change
-
-552,204
-
Total reported value, excl. options
-
$2,481,784,291
-
Value change
-
-$33,967,136
-
Put/Call ratio
-
334%
-
Number of buys
-
128
-
Number of sells
-
-107
-
Price
-
$30.60
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2016
291 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2016.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81,092,174 shares
of 93,104,451 outstanding shares and own 87.1% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (11,321,298 shares), Capital Research Global Investors (7,482,135 shares), VANGUARD GROUP INC (5,196,666 shares), SCOPIA CAPITAL MANAGEMENT LP (4,654,327 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (3,215,862 shares), D. E. Shaw & Co., Inc. (2,904,477 shares), BlackRock Fund Advisors (2,662,989 shares), STATE STREET CORP (2,161,148 shares), BlackRock Institutional Trust Company, N.A. (1,833,291 shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (1,831,028 shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.